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The development of optical techniques for non-invasive
diagnosis of cancer is an ongoing challenge to biomedical
optics. For head and neck cancer we see two main fields of
potential application
1) Screening for second primaries in patients with a his-
tory of oral cancer. This requires imaging techniques or an
approach where a larger area can be scanned quickly.
2) Distinguishing potentially malignant visible primary
lesions from benign ones. Here fiberoptic point measure-
ments can be used as the location of the lesion is known.
This presentation will focus on point measurement tech-
niques.
Various techniques for point measurements have been
developed and investigated clinically for different applica-
tions. Differential Pathlength Spectroscopy is a recently
developed fiberoptic point measurement technique that
measures scattered light in a broad spectrum. Due to the
specific fiberoptic geometry we measure only scattered
photons that have travelled a predetermined pathlength.
This allows us to analyse the spectrum mathematically
and translate the measured curve into a set of parameters
that are related to the microvasculature and to the intrac-
ellular morphology. DPS has been extensively evaluated
on optical phantoms and tested clinically in various clin-
ical applications.
The first measurements in biopsy proven squamous cell
carcinoma showed significant changes in both vascular
and morphological parameters. Measurements on thick
keratinized lesions however failed to generate any vascu-
lar signatures. This is related to the sampling depth of the
standard optical fibers used. Recently we developed a
fiberoptic probe with a ~1 mm sampling depth. Measure-
ments on several leukoplakias showed that with this new
probe we sample just below the keratin layer and can
obtain vascular signatures. The results of a first set of clin-
ical measurements will be presented and the significance
for clinical diagnostics will be discussed.
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